Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;20(5):545-553.
doi: 10.1038/gim.2017.137. Epub 2017 Aug 31.

Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium

Affiliations

Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium

Susan M Wolf et al. Genet Med. 2018 Apr.

Abstract

PurposeThe Clinical Sequencing Exploratory Research (CSER) Consortium encompasses nine National Institutes of Health-funded U-award projects investigating translation of genomic sequencing into clinical care. Previous literature has distinguished norms and rules governing research versus clinical care. This is the first study to explore how genomics investigators describe and navigate the research-clinical interface.MethodsA CSER working group developed a 22-item survey. All nine U-award projects participated. Descriptive data were tabulated and qualitative analysis of text responses identified themes and characterizations of the research-clinical interface.ResultsSurvey responses described how studies approached the research-clinical interface, including in consent practices, recording results, and using a research versus clinical laboratory. Responses revealed four characterizations of the interface: clear separation between research and clinical care, interdigitation of the two with steps to maintain separation, a dynamic interface, and merging of the two. All survey respondents utilized at least two different characterizations. Although research has traditionally been differentiated from clinical care, respondents pointed to factors blurring the distinction and strategies to differentiate the domains.ConclusionThese results illustrate the difficulty in applying the traditional bifurcation of research versus clinical care to translational models of clinical research, including in genomics. Our results suggest new directions for ethics and oversight.

PubMed Disclaimer

Conflict of interest statement

Robert Green receives compensation for speaking or consultation to AIA, GenePeeks, Helix, Illumina, Ohana, Prudential, and Veritas, and is co-founder and advisor to Genome Medical, Inc. Pearl O’Rourke is on a Bioethics Advisory Committee for Takeda.

References

    1. Wolf SM, Burke W, Koenig BA. Mapping the ethics of translational genomics: situating return of results and navigating the research–clinical divide. J Law Med Ethics 2015;43:486–501. - PMC - PubMed
    1. Green RC, Goddard KAB, Jarvik GP et al. The Clinical Sequencing Exploratory Research Consortium: accelerating the evidence-based practice of genomic medicine. Am J Hum Genet 2016;98:1051–1066. - PMC - PubMed
    1. National Institutes of Health. RFA-HG-10-017: Clinical Sequencing Exploratory Research (U01). https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-10-017.html. Accessed 12 March 2017.
    1. Berg J, Amendola LM, Eng C et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med 2013;15:860–867. - PMC - PubMed
    1. Henderson GE, Wolf SM, Kuczynski KJ et al. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics 2014;42:344–355. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources